Dear readers of ADxS.org, please forgive the disruption.

ADxS.org needs about $19740 in 2023. In 2022 we received donations from third parties of about $ 13870. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2023 would be over after a few days. This donation request is displayed 12,000 times a week, but only 140 people donate. If you find ADxS.org useful, please take a minute and support ADxS.org with your donation. Thank you!

Since 01.06.2021 ADxS.org is supported by the non-profit ADxS e.V..

$0 of $19740 - as of 2023-01-03
0%
Header Image
Venlaflaxine for ADHD

Sitemap

Venlaflaxine for ADHD

Brand names of venlaflaxin include: Trevilor (D), Efexor (CH), Efectin (A)

Venaflaxin came on the market in 1993 and is approved only for adults (18 years and older).1

Venlaflaxine acts primarily at the serotonin level, secondarily at the norepinephrine level as a reuptake inhibitor (SSNRI = selective serotonin-norepinephrine reuptake inhibitor), and even less so at the dopamine level.1

Venlaflaxine has been tested in ADHD in only a few studies with a small number of subjects. Improvement in ADHD symptoms was very modest, while side effects were substantial.2
We therefore advise against the use of venlaflaxine for ADHD.

ATTENTION:
Regarding the entire group of serotonin reuptake inhibitors, there are concerns about their use in ADHD.
See Notes on serotonin reuptake inhibitors (SSRIs) in ADHD In the article Medications for ADHD - Overview.

Diese Seite wurde am 09.08.2022 zuletzt aktualisiert.